1 – 15 of 15
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
PlyKp104, a Novel Phage Lysin for the Treatment of Klebsiella pneumoniae, Pseudomonas aeruginosa, and Other Gram-Negative ESKAPE Pathogens
(
- Contribution to journal › Article
- 2022
-
Mark
Use of the Hollow-Fiber Infection Model to Measure the Effect of Combination Therapy of Septic Shock Exposures of Meropenem and Ciprofloxacin against Intermediate and Resistant Pseudomonas aeruginosa Clinical Isolates
(
- Contribution to journal › Article
- 2021
-
Mark
Thrombin-derived C-terminal peptide reduces Candida-induced inflammation and infection in vitro and in vivo
(
- Contribution to journal › Article
- 2020
-
Mark
A phase 2 randomized, double-blind, placebo-controlled trial of MHAA4549A, a monoclonal antibody, plus oseltamivir in patients hospitalized with severe influenza a virus infection
(
- Contribution to journal › Article
- 2018
-
Mark
Reply to Dookie et al., “Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis”
(
- Contribution to journal › Letter
-
Mark
What is resistance? Impact of phenotypic versus molecular drug resistance testing on therapy for multi-and extensively drug-resistant tuberculosis
(
- Contribution to journal › Article
- 2017
-
Mark
The nonantibiotic macrolide em703 improves survival in a model of quinolone-treated pseudomonas aeruginosa airway infection
(
- Contribution to journal › Article
-
Mark
Subinhibitory concentrations of bacteriostatic antibiotics induce relA-dependent and relA-independent tolerance to β-lactams
(
- Contribution to journal › Article
- 2016
-
Mark
Novel engineered peptides of a phage lysin as effective antimicrobials against multidrug-resistant Acinetobacter baumannii
(
- Contribution to journal › Article
- 2010
-
Mark
Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus
(
- Contribution to journal › Article
- 1998
-
Mark
Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes
(
- Contribution to journal › Article
- 1995
-
Mark
CP-115,953 stimulates cytokine production by lymphocytes
(
- Contribution to journal › Article
- 1994
-
Mark
Limited effects of temafloxacin compared with ciprofloxacin on T- lymphocyte function
(
- Contribution to journal › Debate/Note/Editorial
- 1991
-
Mark
Inhibitory effects of recombinant human cystatin C on human coronaviruses
(
- Contribution to journal › Article
- 1990
-
Mark
Ciprofloxacin does not inhibit mitochondrial functions but other antiboitics do
(
- Contribution to journal › Article